- Cell responses to heat shock proteins 60, 65, 70 and synthetic hsp-derived peptides in patients with juvenile idiopathic arthritis2004 | Publication without faculty affiliation
- Juvenile idiopathic arthritis and uveitisPublication without faculty affiliation
- Tocilizumab in the treatment of juvenile idiopathic arthritis2019 | Publication without faculty affiliation
- Development of Crohn’s disease during the course of HLA B27 + juvenile idiopathic arthritis2009 | Central Library of Charles University
- Development of Crohn’s disease during the course of HLA B27 + juvenile idiopathic arthritis2009 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Development of Crohn?s disease during the course of HLA B27 + juvenile idiopathic arthritis2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- Methotrexate therapy may prevent the onset of uveitis in juvenile idiopathic arthritis2013 | First Faculty of Medicine
- Current possibilities of juvenile idiopathic arthritis treatment2018 | First Faculty of Medicine
- Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis2012 | First Faculty of Medicine
- Oligoarticular form of juvenile idiopathic arthritis with uveitis2009 | Central Library of Charles University, Third Faculty of Medicine
- Association between lean mass and fractures in patients with anamnesis of juvenile idiopathic arthritis2010 | First Faculty of Medicine
- Anti-keratin antibodies in patients with juvenile idiopathic arthritis2001 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Increased histone citrullination in juvenile idiopathic arthritis2022 | Central Library of Charles University, Second Faculty of Medicine
- Juvenile idiopathic arthritis2006 | First Faculty of Medicine
- Serum sclerostin in high-activity adult patients with juvenile idiopathic arthritis2014 | First Faculty of Medicine
- Recommendations for the Management of Uveitis Associated with Juvenile Idiopathic Arthritis: The Czech and Slovak Adaptation of the SHARE Initiative2020 | First Faculty of Medicine, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Anti-cyclic citrullinated peptide antibodies in patients with juvenile idiopathic arthritis2002 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Can ultrasound help to overcome uncertainty in clinical joint assessment in juvenile idiopathic arthritis?2023 | First Faculty of Medicine
- Expanded population of low-density neutrophils in juvenile idiopathic arthritis2023 | Central Library of Charles University, Second Faculty of Medicine
- Methotrexate Withdrawal at 6 vs 12 Months in Juvenile Idiopathic Arthritis in Remission A Randomized Clinical Trial2010 | First Faculty of Medicine
- Methotrexate bioavailability after oral and subcutaneous administration in children with juvenile idiopathic arthritis2009 | First Faculty of Medicine
- Immunomodulation of neutrophils and platelets by TNF blockage in patients with juvenile idiopathic arthritis2022 | Central Library of Charles University, Second Faculty of Medicine
- Systemic juvenile idiopathic arthritis2005 | First Faculty of Medicine
- The therapeutics of juvenile idiopathic arthritis +12001 | First Faculty of Medicine
- Frequency of anti-hsp60,-65 and-70 antibodies in sera of patients with juvenile idiopathic arthritis2006 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Treatment of Juvenile Idiopathic arthritis2005 | First Faculty of Medicine
- Opportunistic infections in immunosuppressed patients with juvenile idiopathic arthritis: analysis by the Pharmachild Safety Adjudication Committee2020 | First Faculty of Medicine
- Association of single nucleotide polymorphisms within cytokine genes with juvenile idiopathic arthritis in the Czech population2004 | First Faculty of Medicine, Faculty of Physical Education and Sport, Second Faculty of Medicine
- Baricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trial2023 | Publication without faculty affiliation